• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005年中国癌症发病率和死亡率负担两种估算方法的比较

A comparison of two methods to estimate the cancer incidence and mortality burden in China in 2005.

作者信息

Ren Jian-Song, Chen Wan-Qing, Shin Hai-Rim, Ferlay Jacques, Saika Kumiko, Zhang Si-Wei, Bray Freddie

机构信息

Section of Cancer Information, International Agency for Research on Cancer, France.

出版信息

Asian Pac J Cancer Prev. 2010;11(6):1587-94.

PMID:21338201
Abstract

Knowledge of the cancer profile is an important step in planning rational cancer control programs and evaluation of their impact. Due to rapid changes in cancer incidence in China, national surveys may be insufficiently timely to provide adequate descriptions of the national burden. To evaluate the utility of cancer registries in describing the national cancer profile, this study compared two methods of estimating national cancer-specific incidence and mortality in China 2005, based on the Third National Death Survey (method I) as compared with registry material (method II). A total of 2.6 million cancer cases and 1.8 million cancer deaths were estimated by method I, as compared to 2.8 million cancer cases and 1.9 million cancer deaths using method II. The higher level of burden using the latter method in part may be due to a sizable differential in the magnitude of incidence rates across registries for certain cancer sites. Most cancer registries have been located in relatively more developed urban areas, or rural areas associated with higher risk for certain cancers. There are substantial differences in the cancer profile between urban and rural communities in China, and there may be concerns regarding the national representativeness of the data aggregated from this set of cancer registries. Timely and reliable estimation of cancer can only be realized if accurate information is available from cancer registries covering representative samples of the country.

摘要

了解癌症概况是规划合理的癌症控制项目及其效果评估的重要一步。由于中国癌症发病率变化迅速,全国性调查可能不够及时,无法充分描述全国癌症负担情况。为评估癌症登记处对于描述全国癌症概况的作用,本研究比较了两种估计2005年中国特定癌症发病率和死亡率的方法,一种基于第三次全国死因调查(方法I),另一种基于登记处资料(方法II)。方法I估计共有260万癌症病例和180万癌症死亡病例,而方法II估计有280万癌症病例和190万癌症死亡病例。后一种方法得出的负担水平较高,部分原因可能是某些癌症部位登记处的发病率在数值上存在相当大的差异。大多数癌症登记处位于相对发达的城市地区,或某些癌症风险较高的农村地区。中国城乡社区的癌症概况存在很大差异,因此可能有人担心从这组癌症登记处汇总的数据缺乏全国代表性。只有从覆盖全国代表性样本的癌症登记处获得准确信息,才能及时、可靠地估计癌症情况。

相似文献

1
A comparison of two methods to estimate the cancer incidence and mortality burden in China in 2005.2005年中国癌症发病率和死亡率负担两种估算方法的比较
Asian Pac J Cancer Prev. 2010;11(6):1587-94.
2
Representativeness of population-based cancer registration in China--comparison of urban and rural areas.中国基于人群的癌症登记的代表性——城乡比较。
Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):559-64.
3
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
4
[Incidence and mortality of liver cancer in China: an analysis on data from the National Registration System between 2003 and 2007].中国肝癌的发病率与死亡率:基于2003年至2007年国家登记系统数据的分析
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jun;33(6):547-53.
5
Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.中国乳腺癌面临的挑战与筛查:来自当前登记数据和人群筛查研究的经验教训
Oncologist. 2015 Jul;20(7):773-9. doi: 10.1634/theoncologist.2014-0351. Epub 2015 May 22.
6
[Trend analysis and prediction of cancer incidence in China].[中国癌症发病率的趋势分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):581-6.
7
Time trends in cancer mortality in China: 1987-1999.中国癌症死亡率的时间趋势:1987 - 1999年
Int J Cancer. 2003 Sep 20;106(5):771-83. doi: 10.1002/ijc.11300.
8
[Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].[2003 - 2007年中国部分癌症登记地区子宫体癌流行病学]
Zhonghua Fu Chan Ke Za Zhi. 2012 Jun;47(6):445-51.
9
[Estimation of cancer incidence and mortality in China in 2004-2005].[2004 - 2005年中国癌症发病率与死亡率估算]
Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):664-8.
10
Projection of burden of cancer mortality for India, 2011-2026.2011 - 2026年印度癌症死亡负担预测。
Asian Pac J Cancer Prev. 2013;14(7):4387-92.

引用本文的文献

1
Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005-2014) Retrospective Study.中国非小细胞肺癌患者化疗使用情况的变化及影响因素:一项多中心10年(2005 - 2014年)回顾性研究
Cancer Manag Res. 2020 Jul 20;12:6033-6044. doi: 10.2147/CMAR.S253789. eCollection 2020.
2
Effect of inhibiting Beclin-1 expression on autophagy, proliferation and apoptosis in colorectal cancer.抑制Beclin-1表达对结直肠癌自噬、增殖和凋亡的影响
Oncol Lett. 2017 Oct;14(4):4319-4324. doi: 10.3892/ol.2017.6687. Epub 2017 Jul 28.
3
Old age at diagnosis increases risk of tumor progression in nasopharyngeal cancer.
鼻咽癌诊断时年龄较大增加了肿瘤进展的风险。
Oncotarget. 2016 Oct 4;7(40):66170-66181. doi: 10.18632/oncotarget.10818.
4
Cancer burden in China: a Bayesian approach.中国的癌症负担:一种贝叶斯方法。
BMC Cancer. 2013 Oct 6;13:458. doi: 10.1186/1471-2407-13-458.
5
Nasopharyngeal carcinoma incidence and mortality in China in 2009.2009年中国鼻咽癌的发病率和死亡率。
Chin J Cancer. 2013 Aug;32(8):453-60. doi: 10.5732/cjc.013.10118. Epub 2013 Jul 18.